ADC Therapeutics SA (NYSE:ADCT)
$ 1.295 +0.035 (+2.78%) Market Cap: 164.71 Mil Enterprise Value: 50.37 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

ADC Therapeutics SA LOTIS-5 Topline Results Call Transcript

Jun 3, 2026 / 08:30 PM GMT
Release Date Price: $3.08 (-2.84%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ADCT.N - ADC Therapeutics SA
ADC Therapeutics SA LOTIS-5 Topline Results Call
Jun 03, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, ladies and gentlemen, and welcome to the Lotus 5 presentation conference call. At this time, all lines are in listen-only mode.

Following the presentation, we will conduct a question-and-answer session.

If at any time during this call you require immediate assistance, please press *0 for the operator.

This call is being recorded on Tuesday, June 2, 2026.

I would now like to turn the conference over to Nicole Riley. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Today, we issued a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot